5J13
Structural basis for TSLP antagonism by the therapeutic antibody Tezepelumab (MEDI9929 / AMG-157)
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SOLEIL BEAMLINE PROXIMA 2 |
| Synchrotron site | SOLEIL |
| Beamline | PROXIMA 2 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2015-12-17 |
| Detector | DECTRIS EIGER X 9M |
| Wavelength(s) | 0.9801 |
| Spacegroup name | P 32 1 2 |
| Unit cell lengths | 51.726, 51.726, 370.028 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 44.796 - 2.298 |
| R-factor | 0.1904 |
| Rwork | 0.189 |
| R-free | 0.21500 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4hk0 chain B; 4HIE chain B |
| RMSD bond length | 0.003 |
| RMSD bond angle | 0.765 |
| Data reduction software | XDS (VERSION Oct 15, 2015) |
| Phasing software | PHASER (2.5.7) |
| Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 55.000 | 2.440 |
| High resolution limit [Å] | 2.298 | 2.298 |
| Rmeas | 0.110 | 0.747 |
| Number of reflections | 25284 | |
| <I/σ(I)> | 14.23 | 1.6 |
| Completeness [%] | 97.0 | 83.8 |
| Redundancy | 8.4 | 4.2 |
| CC(1/2) | 0.998 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 4.6 | 293 | 0.2 M ammonium sulfate 0.1 M sodium acetate pH 4.6 25% w/v polyethylene glycol 4000 |






